• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主要组织相容性复合体I类以及逃脱CD8 + T细胞依赖性监视的小鼠肿瘤的独特抗原表达。

Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance.

作者信息

Ward P L, Koeppen H K, Hurteau T, Rowley D A, Schreiber H

机构信息

Department of Pathology, University of Chicago, Illinois 60637.

出版信息

Cancer Res. 1990 Jul 1;50(13):3851-8.

PMID:2112981
Abstract

The rejection of murine UV-induced skin cancers by normal mice is a striking example of powerful immune surveillance of the normal host against malignant cells. In this study, we show that UV-induced regressor tumors regularly grew progressively and killed mice that were depleted of CD8+ T-cells. Depletion of CD4+ T-cells had no effect, suggesting that CD8+ but not CD4+ T-cells were required for this immune surveillance. To determine whether change in major histocompatibility complex (MHC) class I expression was a frequent event that caused low immunogenicity of tumors or facilitated escape from immune destruction, recently isolated murine tumors of varying degrees of immunogenicity, including highly immunogenic UV-induced regressor, less immunogenic UV-induced progressor, and poorly immunogenic spontaneous progressor tumors, were compared. There was no correlation between the ability of a tumor to grow progressively in a normal immunocompetent host and the level of constitutive class I expression or the level of expression induced in vitro by gamma interferon. (Only 1 of more than 20 progressor tumors analyzed showed complete loss of a MHC class I molecule.) Some progressor variants showed loss of a unique tumor-specific cytotoxic T-lymphocyte-defined antigen, consistent with earlier evidence of antigen loss providing a mechanism for tumor escape. However, most of the host-selected progressor variants retained both MHC class I antigens and the unique tumor antigens that we could detect with cytotoxic T-lymphocyte clones, suggesting that mechanisms other than loss of MHC class I or of the unique target antigen may be involved in escape of some tumors from a highly effective CD8-dependent host surveillance.

摘要

正常小鼠对鼠类紫外线诱导的皮肤癌的排斥反应,是正常宿主对恶性细胞进行强大免疫监视的一个显著例子。在本研究中,我们发现紫外线诱导的消退性肿瘤通常会逐渐进展,并导致CD8 + T细胞耗竭的小鼠死亡。CD4 + T细胞的耗竭没有影响,这表明这种免疫监视需要CD8 + 而非CD4 + T细胞。为了确定主要组织相容性复合体(MHC)I类表达的变化是否是导致肿瘤免疫原性降低或促进其逃避免疫破坏的常见事件,我们比较了最近分离的不同免疫原性程度的鼠类肿瘤,包括高免疫原性的紫外线诱导的消退性肿瘤、低免疫原性的紫外线诱导的进展性肿瘤以及低免疫原性的自发性进展性肿瘤。肿瘤在正常免疫活性宿主中逐渐生长的能力,与组成性I类表达水平或γ干扰素体外诱导的表达水平之间没有相关性。(在分析的20多个进展性肿瘤中,只有1个显示MHC I类分子完全缺失。)一些进展性变体显示出一种独特的肿瘤特异性细胞毒性T淋巴细胞定义抗原的缺失,这与早期关于抗原缺失为肿瘤逃逸提供机制的证据一致。然而,大多数宿主选择的进展性变体既保留了MHC I类抗原,也保留了我们能用细胞毒性T淋巴细胞克隆检测到的独特肿瘤抗原,这表明除了MHC I类或独特靶抗原的缺失之外,其他机制可能也参与了一些肿瘤从高效的CD8依赖性宿主监视中逃逸的过程。

相似文献

1
Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance.主要组织相容性复合体I类以及逃脱CD8 + T细胞依赖性监视的小鼠肿瘤的独特抗原表达。
Cancer Res. 1990 Jul 1;50(13):3851-8.
2
Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.对通过用激活的哈维 - 鼠肉瘤病毒癌基因转染紫外线辐射诱导的C3H小鼠消退肿瘤细胞系所产生的进展变体的免疫反应。
Cancer Res. 1990 Jun 1;50(11):3159-66.
3
Immune selection in murine tumors. Ph.d thesis.小鼠肿瘤中的免疫选择。博士论文。
APMIS Suppl. 2003(106):1-46.
4
Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.对紫外线辐射诱导的退化型与自发进展型C3H小鼠肿瘤细胞之间体细胞杂种的免疫反应。
Cancer Res. 1990 Mar 1;50(5):1544-9.
5
MHC class I restricted T cells and immune surveillance against transplanted ultraviolet light-induced tumors.主要组织相容性复合体I类限制性T细胞与针对移植的紫外线诱导肿瘤的免疫监视
Semin Cancer Biol. 1991 Oct;2(5):321-8.
6
Relationship between inducible H-2 expression and the immunogenicity of murine skin neoplasms. I. Evidence that the immunogenicity of ultraviolet radiation-chemically induced tumors is associated with their susceptibility to gamma-interferon-mediated enhancement of H-2Kk expression.诱导性H-2表达与小鼠皮肤肿瘤免疫原性之间的关系。I. 证据表明,紫外线化学诱导肿瘤的免疫原性与其对γ-干扰素介导的H-2Kk表达增强的敏感性相关。
Transplantation. 1989 Mar;47(3):533-42.
7
Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.一种能够抑制抗紫外线肿瘤免疫反应的克隆化紫外线诱导抑制性T细胞系的特性分析。
J Immunol. 1986 Mar 1;136(5):1908-16.
8
Dendritic epidermal T cells in ultraviolet-irradiated skin enhance skin tumor growth by inhibiting CD4+ T-cell-mediated immunity.紫外线照射皮肤中的树突状表皮T细胞通过抑制CD4 + T细胞介导的免疫来促进皮肤肿瘤生长。
Cancer Res. 1996 Jun 1;56(11):2607-15.
9
Antigenic cancer cells that escape immune destruction are stimulated by host cells.逃避免疫破坏的抗原性癌细胞受到宿主细胞的刺激。
Cancer Res. 1995 Nov 1;55(21):5094-100.
10
Resistance of Ha-ras oncogene-induced progressor tumor variants to tumor necrosis factor and interferon-gamma.哈-拉斯癌基因诱导的进展期肿瘤变体对肿瘤坏死因子和γ干扰素的抗性。
Lymphokine Cytokine Res. 1992 Apr;11(2):79-85.

引用本文的文献

1
CD4 T cells with convergent TCR recombination reprogram stroma and halt tumor progression in adoptive therapy.具有趋同 TCR 重组的 CD4 T 细胞重编程基质并在过继治疗中阻止肿瘤进展。
Sci Immunol. 2024 Sep 13;9(99):eadp6529. doi: 10.1126/sciimmunol.adp6529.
2
Intratumor injection of BCG Ag85A high-affinity peptides enhanced anti-tumor efficacy in PPD-positive melanoma.肿瘤内注射 BCG Ag85A 高亲和力肽增强了 PPD 阳性黑色素瘤的抗肿瘤疗效。
Cancer Immunol Immunother. 2024 Apr 17;73(6):103. doi: 10.1007/s00262-024-03693-7.
3
Local blockade of tacrolimus promotes T-cell-mediated tumor regression in systemically immunosuppressed hosts.
局部阻滞他克莫司可促进系统性免疫抑制宿主中 T 细胞介导的肿瘤消退。
J Immunother Cancer. 2023 Sep;11(9). doi: 10.1136/jitc-2023-006783.
4
Resistance mechanisms in melanoma to immuneoncologic therapy with checkpoint inhibitors.黑色素瘤对免疫肿瘤学检查点抑制剂治疗的耐药机制。
Cancer Drug Resist. 2019 Sep 19;2(3):744-761. doi: 10.20517/cdr.2019.28. eCollection 2019.
5
Predictors of response and resistance to checkpoint inhibitors in solid tumors.实体瘤中检查点抑制剂反应和耐药性的预测指标
Ann Transl Med. 2017 Dec;5(23):468. doi: 10.21037/atm.2017.09.35.
6
Delivery of foreign cytotoxic T lymphocyte epitopes to tumor tissues for effective antitumor immunotherapy against pre-established solid tumors in mice.将外源细胞毒性T淋巴细胞表位递送至肿瘤组织,以对小鼠体内预先形成的实体瘤进行有效的抗肿瘤免疫治疗。
Cancer Immunol Immunother. 2017 Apr;66(4):451-460. doi: 10.1007/s00262-016-1948-9. Epub 2016 Dec 23.
7
T cells in tumor microenvironment.肿瘤微环境中的T细胞。
Tumour Biol. 2016 Jan;37(1):39-45. doi: 10.1007/s13277-015-4241-1. Epub 2015 Oct 18.
8
Targeting cancer-specific mutations by T cell receptor gene therapy.通过T细胞受体基因疗法靶向癌症特异性突变。
Curr Opin Immunol. 2015 Apr;33:112-9. doi: 10.1016/j.coi.2015.02.005. Epub 2015 Feb 27.
9
Recurrence of melanoma following T cell treatment: continued antigen expression in a tumor that evades T cell recruitment.T细胞治疗后黑色素瘤的复发:肿瘤中持续的抗原表达,逃避T细胞募集。
Mol Ther. 2015 Feb;23(2):396-406. doi: 10.1038/mt.2014.215. Epub 2014 Nov 3.
10
TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu.T 细胞受体工程化 T 细胞在治疗实体瘤上面临新的挑战:抗原选择、T 细胞功能和肿瘤微环境的致敏。
Front Immunol. 2013 Nov 8;4:363. doi: 10.3389/fimmu.2013.00363. eCollection 2013.